MIRA INFORM REPORT

 

 

Report Date :

20.03.2014

 

IDENTIFICATION DETAILS

 

Name :

SANJAY MEDICALS AND GENERAL STORES

 

 

Registered Office :

Shop No. 3, L V Complex, Ramlal Chowk, Solapur – 413001, Maharashtra 

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Year of Establishment :

1988

 

 

Capital Investment :

Rs. 2.234 Millions

 

 

Legal Form :

Sole Proprietary Concern

 

 

Line of Business :

Trader of Medicines.

 

 

No. of Employees :

6 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (44)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 8900

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established proprietary concern having satisfactory track record.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The concern can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

State-run banks hired nearly 300000 personnel including more than 94000 officers in the last four years, according to the Indian Banks Association. A study by trade lobby Assocham in September 2013 indicated that banks would need 800000 people in the next six years. It estimated that state-run lenders alone would hire 50000 people in 2013/14.

 

The Competition Commission of India plans to issue final orders within a broad time-frame of one year in matters where it decides to carry out detailed investigations. The number of complaints received by the watchdog which keeps tabs on unfair trade practices in the marketplace.

 

The government has detected custom tax evasion totaling around Rs 37920 mn in 14 states until December. Maharashtra topped the list of Rs 14190 mn followed by Andhra Pradesh at Rs 8140 mn, Gujarat Rs 5240 mn, Karnataka Rs 1670 mn and Tamilnadu Rs 1610 mn.

 

Connaught Place in New Delhi slipped four notches to become the world’s eighth most expensive office locations. London’s West End is the world’s most expensive office market.

 

There are 4.072 mn number of high value spenders under the scanner of the income tax department. The income tax department has information that they have made cash deposits announcing to Rs 1 mn or more in their savings bank accounts in the current financial year. It plans to check potential evasion before the closing of the financial year on March 31.

 

Estimated pharmaceutical sales in the country for 2016 is $ 27 bn. It is 14.4 per cent higher than a year ago. The life sciences and health care industry is up against challenges such as quality management, says a recent Deloitte report.

 

The gross non-performing assets of listed banks rose 35.2 % to Rs 2.43 lakh crore during the first three months of the financial year. In absolute terms, the 40 listed banks added Rs 3386 crore to their gross NPAs in nine months with the State Bank of India leading with the State Bank of India leading with an accretion of Rs 16610 crore.

 

The inflow of smuggled gold doubled in 2013 following restrictions to curb the supply from official channels to contain the current account deficit. China surpassed India in the demand for gold for the first time in 2013 due to liberalization of gold trading norms by its local governments.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Santosh Akul

Designation :

Key Executive

Contact No.:

91-9890641149

Date :

18.03.2014

 

 

LOCATIONS

           

Registered Office/ Factory :

Shop No. 3, L V Complex, Ramlal Chowk, Solapur – 413001, Maharashtra, India  

Tel. No.:

91-217-2321261

Mobile No.:

91-9890641149 (Mr. Santosh Akul)

Fax No.:

Not Available

E-Mail :

sanjaymedicals87@gmail.com

Area :

450 Sq. ft.

Location :

Owned

 

 

SOLE PROPRIETOR

 

Name :

Mr. Pramod Ramesh Akul

Designation :

Proprietor

Date of Birth/Age :

45 Years

Qualification :

B. Pharmacy

 

 

KEY EXECUTIVES

 

Name :

Mr. Santosh Akul

Designation :

Key Executive

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of Medicines.

 

 

Agencies Held :

·         Roche Products (India) Private Limited

Chiron Panacea

Aventis Pharma Limited

Abbott India

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit [15 Days]

 

 

GENERAL INFORMATION

 

Suppliers :

·         Roche Products (India) Private Limited

Chiron Panacea

Aventis Pharma Limited

Abbott India

 

 

Customer :

Ashwini Hospital, Solapur

 

 

No. of Employees :

6 (Approximately)

 

 

Bankers :

·         Solapur Janata Sahakari Bank Limited

Railway Line Branch, Solapur, Maharashtra, India

 

 

Facilities :

Cash Credit : Rs. 0.500 Million

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S.V. Soni And Company

Chartered Accountants

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2013

 

Capital Investment :

 

Owned :

Rs. 2.234 Millions

Borrowed :

--

Total :

Rs. 2.234 Millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

The above information has been parted by Mr. Santosh Akul [Key Executive]

 

Note : Sole Proprietary and Partnership concerns are exempted from filing their financials with the Government Authorities or Registry.

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

SHAREHOLDERS FUNDS

 

 

 

1] Proprietor’s Capital

2.234

0.729

0.612

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

0.000

0.000

0.000

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

2.234

0.729

0.612

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.781

0.677

0.709

TOTAL BORROWING

0.781

0.677

0.709

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

3.015

1.406

1.321

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

0.857

0.851

0.944

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.267

0.013

0.013

DEFERRED TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

1.153

0.320

 

 

Sundry Debtors

0.342

1.045

 

 

Cash & Bank Balances

0.136

0.151

 

 

Other Current Assets

1.265

0.689

 

 

Loans & Advances

0.080

0.000

 

Total Current Assets

2.976

2.205

1.835

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

1.055

1.629

 

Other Current Liabilities

0.030

0.034

 

 

Provisions

0.000

0.000

 

Total Current Liabilities

1.085

1.663

1.471

Net Current Assets

1.891

0.542

0.364

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

3.015

1.406

1.321

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

9.049

5.961

4.491

 

 

Other Income

0.095

0.073

0.047

 

 

TOTAL                                    

9.144

6.034

4.538

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of goods sold

7.801

5.350

4.058

 

 

Accounting writing

0.032

0.018

 

 

 

Advertisement expenses

0.002

0.002

 

 

 

Bank charges

0.006

0.001

 

 

 

Bank interest

0.009

0.018

 

 

 

Bonus

0.031

0.014

 

 

 

Computer expenses

0.003

0.003

 

 

 

Conveyance expenses

0.017

0.015

 

 

 

Corporation tax

0.008

0.000

 

 

 

Licence fees

0.006

0.000

 

 

 

Insurance

0.016

0.016

 

 

 

Light bill expenses

0.059

0.000

 

 

 

Petrol expenses

0.028

0.017

 

 

 

Postage and Courier expenses

0.006

0.008

 

 

 

Printing and stationery expenses

0.008

0.004

 

 

 

Repairs and Maintenance expenses

0.002

0.003

 

 

 

Salary

0.367

0.216

 

 

 

Shop expenses

0.029

0.023

 

 

 

Staff welfare expenses

0.008

0.007

 

 

 

Telephone bill expenses

0.022

0.000

 

 

 

Transportation expenses

0.001

0.000

 

 

 

Vehicles repair expenses

0.007

0.018

 

 

 

Vat Tax

0.039

0.088

 

 

 

Other Expenses

0.000

0.018

 

 

 

TOTAL                                    

8.507

5.839

4.489

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION                                  

0.637

0.195

 

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

0.083

0.093

 

 

 

 

 

 

 

NET PROFIT

0.554

0.102

0.049

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

6.06

1.69

1.08

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

6.12

1.71

1.09

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

14.45

3.34

1.76

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.25

0.14

0.08

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.35

0.93

1.16

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.74

1.33

1.25

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. in Millions)

(Rs. in Millions)

(Rs. in Millions)

Proprietor’s Capital

0.612

0.729

2.234

Share Application Money

0.000

0.000

0.000

Reserves & Surplus

0.000

0.000

0.000

(Accumulated Losses)

0.000

0.000

0.000

Net worth

0.612

0.729

2.234

 

 

 

 

Secured Loans

0.000

0.000

0.000

Unsecured Loans

0.709

0.677

0.781

Total borrowings

0.709

0.677

0.781

Debt/Equity ratio

1.158

0.929

0.350

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. in Millions)

(Rs. in Millions)

(Rs. in Millions)

Sales

4.491

5.961

9.049

 

 

32.732

51.803

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. in Millions)

(Rs. in Millions)

(Rs. in Millions)

Sales

4.491

5.961

9.049

Profit

0.049

0.102

0.554

 

1.09%

1.71%

6.12%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

No

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

No

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

TRADE REFERENCES:

 

·         Roche Products (India) Private Limited

Chiron Panacea

Aventis Pharma Limited

Abbott India

Ashwini Hospital, Solapur

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 61.10

UK Pound

1

Rs. 101.41

Euro

1

Rs. 85.08

 

 

INFORMATION DETAILS

 

Information Gathered by :

HNA

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

44

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.